TGA warns against advertising mLs and units pricing
12 Aug 2019

The Therapeutic Goods Administration (TGA) has warned doctors against advertising a price per ‘units’ or ‘mLs’ for cosmetic injections.
The warnings came in letters sent to individual doctors following complaints made to the TGA. The letters stated that such pricing “makes an indirect reference to a Schedule 4 (Prescription Only) substance as it is not possible to purchase units of a service”.
The letter further stated:
“Advertisements for cosmetic services MUST NOT specify trade names of products (e.g., Belkyra) containing Schedule 4 substances or ingredients (e.g., deoxycholic acid) that are Schedule 4 substances, or make indirect reference to Schedule 4 substances from which they can be identified as this is a breach of the Act.”
Guidance on legal obligations when advertising therapeutic goods can be found on the TGA’s advertising hub.
Not yet subscribed to receive our medico-legal blog? Scroll down to subscribe and stay connected.
This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.
Understanding changes to the Fair Work Act
What are the changes to the Fair Work Act and what is my role?
22 Jul 2025
Using AI tools for record management in doctor consultations
What are the considerations for using an AI scribe tool in your practice?
22 Jul 2025
A health practitioners guide to social media
What are the laws and guidelines that impact social media for practitioners?
22 Jul 2025
Understanding Voluntary Assisted Dying laws
What are the laws and processes in place for VAD and what is my role?
22 Jul 2025